05:35 AM EDT, 10/23/2026 (MT Newswires) -- Biovica International (BIOVIC-B.ST) conditionally raised 29.2 million kronor through a fully subscribed rights issue of 97,303,733 new B shares, the Swedish biotechnology group said Friday. Under the issue, 49.97% of the shares were subscribed for with subscription rights, while 21.14% were subscribed for without subscription rights. The company allocated the remaining 28.89% to HDF Cancer Monitoring in its capacity as guarantor in the rights issue. Following HDF Cancer Monitoring's participation in the rights issue, its stake in the company will exceed the relevant threshold under Swedish law of 29.9% and will require approval from the Inspectorate of Strategic Products.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.